DBiT-seq Platform & Data Portal

About AtlasXomics

AtlasXomics is a spatial biology company focused on bridging epigenomics and pathology to transform biomedical discovery. The company's core technology, DBiT-seq, is a spatial barcoding platform that enables multi-modal mapping of the epigenome and transcriptome at cellular resolution. With validation from over 170 labs worldwide and publications in top-tier journals, AtlasXomics is positioned as a leader in the emerging spatial epigenomics field, offering both innovative assay kits and a code-free bioinformatics pipeline to democratize access to this complex data.

Therapeutic Areas